Will the trend of stem cells making headlines continue as it has over the past decade? On one hand, their use has been protested by various groups as activist investor Jason Hope comments. Yet, they’ve also been proclaimed as a top means of eradicating certain diseases, overall, those concerning anti aging research. Numerous independent companies and biotech giants are pushing ahead with projects involving stem cells amid technological advancements, global connectivity, and the union between tech and medicine.
According to Jason Hope, stem cells have secured for themselves a place in the spotlight for quite some time. It has been over 20 years since scientists first extracted stem cells from a human embryo then effectively grew the cells. This action allowed researchers to grow “parent” cells that can produce new cells within a person’s body.
The medical sector rejoiced as hope was placed in this potentially effective treatment for conditions like Alzheimer’s, Parkinson’s, heart disease, and stroke. While the initial breakthrough seemed promising, unfortunately, Jason Hope instills, significant strides have not culminated in well-researched stem cell therapy that has the backing of medical associations nor is readily accepted in the scientific community.

In reality, the only commonly used treatments with stem cells involve using cells of matching donors to grow blood cells for individuals with varying blood disorders. As an expert in the field of longevity and anti-aging, Jason Hope believes more research must be done to fully utilize the major widespread medical benefits that lay untapped with stem cells.
Hope is a philanthropic entrepreneur who devotes much of his medical endeavors through a group called SENS Organization. He understands that the general public can formulate distrust when overly eager companies produce lofty claims or tout treatments that have not yet been fully vetted medically. Therefore, Jason Hope actively promotes long-term research that can help maximize the safe, successful, and effective use of stem cell treatments.